Johnson & Johnson 

€0
42062
+€0+0% 今天

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

即將到來

財報

14Apr預期
Q4 2025
下一步
2.11
2.17
2.22
2.28
預期EPS
2.2831767088
實際EPS
不適用

其他人也在關注

此清單是根據在 Stock Events 上追蹤 JNJ.MU 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Show more...
執行長
Mr. Joaquin Duato
員工
141700
國家
美國
ISIN
US4781601046

上市

0 Comments

分享你的想法

FAQ

Johnson & Johnson 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Johnson & Johnson 的股票以代號 JNJ.MU 進行交易。
Johnson & Johnson 下一次財報日期是什麼時候?
Johnson & Johnson 將於 April 14, 2026 公布下一次財報。
Johnson & Johnson 上一季度的財報如何?
JNJ.MU 上一季度的財報為每股 2.11 EUR,預估為 2.11 EUR,帶來 -0.12% 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Johnson & Johnson 有多少名員工?
截至 April 12, 2026,公司共有 141,700 名員工。
Johnson & Johnson 位於哪個產業?
Johnson & Johnson從事於Health & Wellness產業。
Johnson & Johnson 何時完成拆股?
Johnson & Johnson 最近沒有進行任何拆股。
Johnson & Johnson 的總部在哪裡?
Johnson & Johnson 的總部位於 美國 的 New Brunswick。